Blauvelt, A., Langley, R.G., Peris, K., Silvestre, J.F., Katoh, N., Tauber, M., Pinter, A., Ameen, M., Gooderham, M., Øland, C.B., Tindberg, A.-M., Gjerum, L. and Reich, K. 2024. Continuous Tralokinumab Treatment over 4 Years in Adults with Moderate-to-Severe Atopic Dermatitis Provides Long-Term Disease Control. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s376. DOI:https://doi.org/10.25251/skin.8.supp.376.